Cohen Gabriel M, Langer Arielle L, Sima Hamid, Chang Charissa, Troy Kevin, Taimur Sarah
Division of Infectious Diseases, New York University School of Medicine, New York, NY.
Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY.
Transplant Direct. 2018 Nov 27;4(12):e411. doi: 10.1097/TXD.0000000000000850. eCollection 2018 Dec.
Human herpesvirus-8 (HHV-8) remains best known as an oncogenic virus, but nonneoplastic disease manifestations, such as bone marrow failure or hemophagocytic lymphohistiocytosis (HLH) have gained greater recognition in recent years. In organ transplantation, HHV-8 infection commonly occurs with reactivation of latent virus among recipients from endemic regions of the world or due to transmission from the organ donor. We describe a case of HHV-8-associated HLH in a liver transplant recipient at increased risk for primary infection. Our case highlights the risk of non-donor-derived, posttransplant primary HHV-8 infection, and demonstrates that HLH can be a life-threatening complication of this infection.
人类疱疹病毒8型(HHV-8)一直以来最为人所知的是它作为一种致癌病毒,但近年来,诸如骨髓衰竭或噬血细胞性淋巴组织细胞增生症(HLH)等非肿瘤性疾病表现已得到更多认识。在器官移植中,HHV-8感染常见于来自世界流行地区的受者体内潜伏病毒的重新激活,或因器官供体传播所致。我们描述了一例肝移植受者发生HHV-8相关HLH的病例,该受者存在原发性感染风险增加的情况。我们的病例突出了移植后非供体来源的原发性HHV-8感染风险,并表明HLH可能是这种感染的一种危及生命的并发症。